KAHRAMAN, R. Et Al. 2017. Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?. THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.13 , 1295-1301.

KAHRAMAN, R., ÇALHAN, T., SAHIN, A., Özdil, K., CALISKAN, Z., Bireller, E. S., ... Cakmakoglu, B.(2017). Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?. THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.13, 1295-1301.

KAHRAMAN, Resul Et Al. "Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?," THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.13, 1295-1301, 2017

KAHRAMAN, Resul Et Al. "Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?." THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.13, pp.1295-1301, 2017

KAHRAMAN, R. Et Al. (2017) . "Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?." THERAPEUTICS AND CLINICAL RISK MANAGEMENT , vol.13, pp.1295-1301.

@article{article, author={Resul KAHRAMAN Et Al. }, title={Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?}, journal={THERAPEUTICS AND CLINICAL RISK MANAGEMENT}, year=2017, pages={1295-1301} }